These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 17002294)
1. Determinants of specificity of MDM2 for the activation domains of p53 and p65: proline27 disrupts the MDM2-binding motif of p53. Zondlo SC; Lee AE; Zondlo NJ Biochemistry; 2006 Oct; 45(39):11945-57. PubMed ID: 17002294 [TBL] [Abstract][Full Text] [Related]
2. The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2. Uesugi M; Verdine GL Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14801-6. PubMed ID: 10611293 [TBL] [Abstract][Full Text] [Related]
3. The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins. Melcher K J Mol Biol; 2000 Sep; 301(5):1097-112. PubMed ID: 10966808 [TBL] [Abstract][Full Text] [Related]
4. Structural details on mdm2-p53 interaction. Chi SW; Lee SH; Kim DH; Ahn MJ; Kim JS; Woo JY; Torizawa T; Kainosho M; Han KH J Biol Chem; 2005 Nov; 280(46):38795-802. PubMed ID: 16159876 [TBL] [Abstract][Full Text] [Related]
5. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins. Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548 [TBL] [Abstract][Full Text] [Related]
6. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site. Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748 [TBL] [Abstract][Full Text] [Related]
7. Direct observations of conformational distributions of intrinsically disordered p53 peptides using UV Raman and explicit solvent simulations. Xiong K; Zwier MC; Myshakina NS; Burger VM; Asher SA; Chong LT J Phys Chem A; 2011 Sep; 115(34):9520-7. PubMed ID: 21528875 [TBL] [Abstract][Full Text] [Related]
8. Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2. Allende-Vega N; McKenzie L; Meek D Mol Cell Biochem; 2008 Sep; 316(1-2):99-106. PubMed ID: 18548200 [TBL] [Abstract][Full Text] [Related]
9. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft. Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534 [TBL] [Abstract][Full Text] [Related]
10. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Kussie PH; Gorina S; Marechal V; Elenbaas B; Moreau J; Levine AJ; Pavletich NP Science; 1996 Nov; 274(5289):948-53. PubMed ID: 8875929 [TBL] [Abstract][Full Text] [Related]
11. p53 modulates the activity of the GLI1 oncogene through interactions with the shared coactivator TAF9. Yoon JW; Lamm M; Iannaccone S; Higashiyama N; Leong KF; Iannaccone P; Walterhouse D DNA Repair (Amst); 2015 Oct; 34():9-17. PubMed ID: 26282181 [TBL] [Abstract][Full Text] [Related]
12. The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif. Xu H; Ye H; Osman NE; Sadler K; Won EY; Chi SW; Yoon HS Biochemistry; 2009 Dec; 48(51):12159-68. PubMed ID: 19916559 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of the interaction between MDM2 and p53. Schon O; Friedler A; Bycroft M; Freund SM; Fersht AR J Mol Biol; 2002 Oct; 323(3):491-501. PubMed ID: 12381304 [TBL] [Abstract][Full Text] [Related]
14. Design of a novel MDM2 binding peptide based on the p53 family. Madhumalar A; Lee HJ; Brown CJ; Lane D; Verma C Cell Cycle; 2009 Sep; 8(17):2828-36. PubMed ID: 19713735 [TBL] [Abstract][Full Text] [Related]
15. Molecular recognition of p53 and MDM2 by USP7/HAUSP. Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402 [TBL] [Abstract][Full Text] [Related]
16. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo. Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449 [TBL] [Abstract][Full Text] [Related]
17. Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction. Shan B; Li DW; Brüschweiler-Li L; Brüschweiler R J Biol Chem; 2012 Aug; 287(36):30376-84. PubMed ID: 22807444 [TBL] [Abstract][Full Text] [Related]
18. A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors. Chen R; Zhou J; Qin L; Chen Y; Huang Y; Liu H; Su Z Biochemistry; 2017 Jun; 56(25):3273-3282. PubMed ID: 28581721 [TBL] [Abstract][Full Text] [Related]
19. Conservation of Affinity Rather Than Sequence Underlies a Dynamic Evolution of the Motif-Mediated p53/MDM2 Interaction in Ray-Finned Fishes. Mihalič F; Arcila D; Pettersson ME; Farkhondehkish P; Andersson E; Andersson L; Betancur-R R; Jemth P Mol Biol Evol; 2024 Feb; 41(2):. PubMed ID: 38301272 [TBL] [Abstract][Full Text] [Related]
20. Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition. Shin JS; Ha JH; Lee DH; Ryu KS; Bae KH; Park BC; Park SG; Yi GS; Chi SW Cell Cycle; 2015; 14(4):533-43. PubMed ID: 25591003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]